Pharmacogenomic analysis of the triplet combination of gemcitabine, oxaliplatin and cetuximab as salvage therapy for metastatic colorectal cancer (mCRC) patients

  1. Bandres, E.
  2. Rodriguez, J.
  3. Hernandez, A.
  4. Bitarte, N.
  5. Ramirez, N.
  6. Diaz-Gonzalez, J. A.
  7. Chopitea, A.
  8. Ponz, M.
  9. Zarate, R. N.
  10. Garcia-Foncillas, J.
Aldizkaria:
EJC SUPPLEMENTS

ISSN: 1359-6349

Argitalpen urtea: 2009

Alea: 7

Zenbakia: 2

Orrialdeak: 113-113

Biltzarra: 15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology

Mota: Biltzar ekarpena

DOI: 10.1016/S1359-6349(09)70388-X GOOGLE SCHOLAR
Datuen iturria: WoS